33 employees
A clinical-stage biopharmaceutical company identifying and developing therapeutics for the treatment of fungal and bacterial infections.
2011
$33M
from 1 investors over 1 rounds
Matinas BioPharma raised $33M on May 17, 2013
Investors: SternAegis Ventures